Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
46
CME Quote, Financials, Valuation and Earnings
Last price:
$278.86
Seasonality move
:
5.99%
Day range:
$273.71 - $279.34
52-week range:
$193.25 - $290.79
Dividend yield:
3.82%
P/E ratio:
27.92x
P/S ratio:
15.90x
P/B ratio:
3.70x
Volume:
2.5M
Avg. volume:
2.5M
1-year change:
40.61%
Market cap:
$100B
Revenue:
$6.1B
EPS (TTM):
$9.94
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.9B | $4.7B | $5B | $5.6B | $6.1B | |
| Revenue Growth (YoY) | 0.32% | -3.97% | 7.03% | 11.15% | 9.88% | |
| Cost of Revenues | $856.5M | $837M | $753.1M | $828.6M | $850.3M | |
| Gross Profit | $4B | $3.9B | $4.3B | $4.8B | $5.3B | |
| Gross Profit Margin | 82.46% | 82.15% | 85% | 85.15% | 86.13% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $191.3M | $151.7M | $137.4M | $144.4M | $132.7M | |
| Other Inc / (Exp) | $250.9M | $895.3M | $637.1M | $877.3M | $770.8M | |
| Operating Expenses | $1.4B | $1.2B | $1.3B | $1.3B | $1.3B | |
| Operating Income | $2.6B | $2.6B | $3B | $3.4B | $3.9B | |
| Net Interest Expenses | $166.2M | $166.9M | $162.7M | $159.4M | $160.9M | |
| EBT. Incl. Unusual Items | $2.7B | $3.4B | $3.5B | $4.2B | $4.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $615.7M | $736.7M | $799.3M | $927.4M | $1B | |
| Net Income to Company | $2.1B | $2.6B | $2.7B | $3.2B | $3.5B | |
| Minority Interest in Earnings | -$1.2M | $500K | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $2.1B | $2.6B | $2.7B | $3.2B | $3.5B | |
| Basic EPS (Cont. Ops) | $5.88 | $7.30 | $7.41 | $8.87 | $9.69 | |
| Diluted EPS (Cont. Ops) | $5.87 | $7.29 | $7.40 | $8.86 | $9.67 | |
| Weighted Average Basic Share | $357.8M | $358.3M | $358.7M | $359M | $359.4M | |
| Weighted Average Diluted Share | $358.5M | $358.9M | $359.2M | $359.5M | $359.9M | |
| EBITDA | $3.4B | $3.9B | $4B | $4.7B | $5B | |
| EBIT | $2.9B | $3.5B | $3.7B | $4.3B | $4.7B | |
| Revenue (Reported) | $4.9B | $4.7B | $5B | $5.6B | $6.1B | |
| Operating Income (Reported) | $2.6B | $2.6B | $3B | $3.4B | $3.9B | |
| Operating Income (Adjusted) | $2.9B | $3.5B | $3.7B | $4.3B | $4.7B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.3B | $1.4B | $1.5B | $1.6B | |
| Revenue Growth (YoY) | -17.66% | 7.44% | 7.06% | 3.21% | 10.38% | |
| Cost of Revenues | $225M | $185.2M | $204.5M | $206M | $206.7M | |
| Gross Profit | $1B | $1.2B | $1.2B | $1.3B | $1.4B | |
| Gross Profit Margin | 82.05% | 86.25% | 85.81% | 86.16% | 87.41% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $37.4M | $31.8M | $38.3M | $33.1M | $28.5M | |
| Other Inc / (Exp) | $68.7M | $99.7M | $283.1M | $193.7M | $178.5M | |
| Operating Expenses | $303.2M | $302.3M | $323.4M | $322.3M | $327.6M | |
| Operating Income | $725.1M | $859.1M | $913.7M | $959.6M | $1.1B | |
| Net Interest Expenses | $41.5M | $42.5M | $39.9M | $39.9M | $41.7M | |
| EBT. Incl. Unusual Items | $752.3M | $916.3M | $1.2B | $1.1B | $1.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $177.5M | $205.3M | $273.1M | $258.2M | $288.6M | |
| Net Income to Company | $574.8M | $711M | $883.8M | $855.2M | $956.2M | |
| Minority Interest in Earnings | $400K | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $574.4M | $711M | $883.8M | $855.2M | $956.2M | |
| Basic EPS (Cont. Ops) | $1.60 | $1.96 | $2.43 | $2.35 | $2.63 | |
| Diluted EPS (Cont. Ops) | $1.60 | $1.95 | $2.43 | $2.35 | $2.62 | |
| Weighted Average Basic Share | $358.1M | $358.6M | $358.9M | $359.3M | $359.6M | |
| Weighted Average Diluted Share | $358.8M | $359.2M | $359.3M | $359.8M | $360.2M | |
| EBITDA | $892M | $1.1B | $1.3B | $1.2B | $1.4B | |
| EBIT | $793.8M | $958.8M | $1.2B | $1.2B | $1.3B | |
| Revenue (Reported) | $1.3B | $1.3B | $1.4B | $1.5B | $1.6B | |
| Operating Income (Reported) | $725.1M | $859.1M | $913.7M | $959.6M | $1.1B | |
| Operating Income (Adjusted) | $793.8M | $958.8M | $1.2B | $1.2B | $1.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.6B | $4.8B | $5.1B | $5.6B | $6.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $874M | $797.2M | $772.4M | $830.1M | $851M | |
| Gross Profit | $3.7B | $4B | $4.3B | $4.8B | $5.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $187M | $146.1M | $143.9M | $139.2M | $128.1M | |
| Other Inc / (Exp) | $249.3M | $926.3M | $820.5M | $787.9M | $755.6M | |
| Operating Expenses | $1.3B | $1.2B | $1.3B | $1.3B | $1.4B | |
| Operating Income | $2.4B | $2.8B | $3.1B | $3.5B | $4.1B | |
| Net Interest Expenses | $166.8M | $167.9M | $160.1M | $159.4M | $162.7M | |
| EBT. Incl. Unusual Items | $2.5B | $3.5B | $3.7B | $4.1B | $4.7B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $570.7M | $764.5M | $867.1M | $912.5M | $1B | |
| Net Income to Company | $1.9B | $2.8B | $2.9B | $3.2B | $3.6B | |
| Minority Interest in Earnings | -$1.4M | -$500K | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.9B | $2.8B | $2.9B | $3.2B | $3.6B | |
| Basic EPS (Cont. Ops) | $5.34 | $7.68 | $7.88 | $8.79 | $9.97 | |
| Diluted EPS (Cont. Ops) | $5.33 | $7.66 | $7.87 | $8.79 | $9.94 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $3.1B | $4.1B | $4.3B | $4.6B | $5.2B | |
| EBIT | $2.7B | $3.7B | $3.9B | $4.3B | $4.8B | |
| Revenue (Reported) | $4.6B | $4.8B | $5.1B | $5.6B | $6.3B | |
| Operating Income (Reported) | $2.4B | $2.8B | $3.1B | $3.5B | $4.1B | |
| Operating Income (Adjusted) | $2.7B | $3.7B | $3.9B | $4.3B | $4.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.3B | $1.4B | $1.5B | $1.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $225M | $185.2M | $204.5M | $206M | $206.7M | |
| Gross Profit | $1B | $1.2B | $1.2B | $1.3B | $1.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $37.4M | $31.8M | $38.3M | $33.1M | $28.5M | |
| Other Inc / (Exp) | $68.7M | $99.7M | $283.1M | $193.7M | $178.5M | |
| Operating Expenses | $303.2M | $302.3M | $323.4M | $322.3M | $327.6M | |
| Operating Income | $725.1M | $859.1M | $913.7M | $959.6M | $1.1B | |
| Net Interest Expenses | $41.5M | $42.5M | $39.9M | $39.9M | $41.7M | |
| EBT. Incl. Unusual Items | $752.3M | $916.3M | $1.2B | $1.1B | $1.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $177.5M | $205.3M | $273.1M | $258.2M | $288.6M | |
| Net Income to Company | $574.8M | $711M | $883.8M | $855.2M | $956.2M | |
| Minority Interest in Earnings | $400K | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $574.4M | $711M | $883.8M | $855.2M | $956.2M | |
| Basic EPS (Cont. Ops) | $1.60 | $1.96 | $2.43 | $2.35 | $2.63 | |
| Diluted EPS (Cont. Ops) | $1.60 | $1.95 | $2.43 | $2.35 | $2.62 | |
| Weighted Average Basic Share | $358.1M | $358.6M | $358.9M | $359.3M | $359.6M | |
| Weighted Average Diluted Share | $358.8M | $359.2M | $359.3M | $359.8M | $360.2M | |
| EBITDA | $892M | $1.1B | $1.3B | $1.2B | $1.4B | |
| EBIT | $793.8M | $958.8M | $1.2B | $1.2B | $1.3B | |
| Revenue (Reported) | $1.3B | $1.3B | $1.4B | $1.5B | $1.6B | |
| Operating Income (Reported) | $725.1M | $859.1M | $913.7M | $959.6M | $1.1B | |
| Operating Income (Adjusted) | $793.8M | $958.8M | $1.2B | $1.2B | $1.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.6B | $2.8B | $2.7B | $2.9B | $2.9B | |
| Short Term Investments | $100.9M | $115M | $96M | $111.7M | $113.2M | |
| Accounts Receivable, Net | $461.3M | $434.5M | $483.2M | $535.6M | $573.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $302M | $423M | $524.9M | $1.1B | $553.1M | |
| Total Current Assets | $89.3B | $161.8B | $139.1B | $94.9B | $103B | |
| Property Plant And Equipment | $579.2M | $505.3M | $455.5M | $409.5M | $386.2M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $10.8B | $10.5B | $10.5B | $10.5B | $10.5B | |
| Other Intangibles | $22B | $20.7B | $20.4B | $20.2B | $20B | |
| Other Long-Term Assets | $2B | $3.3B | $3.7B | $3.7B | $3.5B | |
| Total Assets | $124.7B | $196.8B | $174.2B | $129.7B | $137.4B | |
| Accounts Payable | $69.3M | $48.8M | $121.4M | $90.6M | $79.9M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $749.8M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $88.1B | $159.6B | $137.6B | $93.3B | $101.5B | |
| Total Current Liabilities | $88.2B | $160.4B | $137.7B | $93.4B | $102.3B | |
| Long-Term Debt | $3.4B | $2.7B | $3.4B | $3.4B | $2.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $98.3B | $169.4B | $147.3B | $103B | $111B | |
| Common Stock | $3.6M | $3.6M | $3.6M | $3.6M | $3.6M | |
| Other Common Equity Adj | $134.9M | $53.5M | -$133.3M | -$55.6M | -$105.5M | |
| Common Equity | $26.3B | $27.4B | $26.9B | $26.7B | $26.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $31.6M | -- | -- | -- | -- | |
| Total Equity | $26.4B | $27.4B | $26.9B | $26.7B | $26.5B | |
| Total Liabilities and Equity | $124.7B | $196.8B | $174.2B | $129.7B | $137.4B | |
| Cash and Short Terms | $1.7B | $2.9B | $2.8B | $3B | $3B | |
| Total Debt | $3.4B | $3.4B | $3.4B | $3.4B | $3.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $936.4M | $2B | $1.6B | $1.4B | $1.4B | |
| Short Term Investments | $105.2M | $109.6M | $105M | $121M | $113.9M | |
| Accounts Receivable, Net | $547M | $608.9M | $723.6M | $628.2M | $770.2M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $290.9M | $498.6M | $542.1M | $642.5M | $455.2M | |
| Total Current Assets | $126.7B | $171B | $131B | $97.3B | $123.4B | |
| Property Plant And Equipment | $528.6M | $493.9M | $440.3M | $396M | $371.2M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $10.5B | $10.5B | $10.5B | $10.5B | $10.5B | |
| Other Intangibles | $20.9B | $20.6B | $20.4B | $20.2B | $19.9B | |
| Other Long-Term Assets | $2B | $3.3B | $3.7B | $3.7B | $3.6B | |
| Total Assets | $160.7B | $205.9B | $166B | $132.1B | $157.8B | |
| Accounts Payable | $51.6M | $80.8M | $97.2M | $111M | $100.2M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $124.2B | $168.4B | $128.9B | $95.2B | $121.3B | |
| Total Current Liabilities | $124.2B | $168.5B | $129B | $96.1B | $121.4B | |
| Long-Term Debt | $3.4B | $3.4B | $3.4B | $2.7B | $3.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $134.1B | $178.2B | $138.7B | $104.9B | $130.8B | |
| Common Stock | $3.6M | $3.6M | $3.6M | $3.6M | $3.6M | |
| Other Common Equity Adj | $83.5M | $28M | -$130.6M | -$86.1M | -$74.8M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $28M | -- | -- | -- | -- | |
| Total Equity | $26.6B | $27.7B | $27.4B | $27.2B | $27B | |
| Total Liabilities and Equity | $160.7B | $205.9B | $166B | $132.1B | $157.8B | |
| Cash and Short Terms | $1B | $2.2B | $1.7B | $1.6B | $1.5B | |
| Total Debt | $3.4B | $3.4B | $3.4B | $3.4B | $3.4B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.1B | $2.6B | $2.7B | $3.2B | $3.5B | |
| Depreciation & Amoritzation | $464.4M | $385.4M | $362.6M | $352.6M | $336.8M | |
| Stock-Based Compensation | $96M | $75.2M | $84.3M | $82.9M | $89.5M | |
| Change in Accounts Receivable | $28.2M | -$45.7M | -$51.1M | -$51.5M | -$39.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.7B | $2.4B | $3.1B | $3.5B | $3.7B | |
| Capital Expenditures | $197.5M | $127.2M | $89.7M | $76.4M | $94M | |
| Cash Acquisitions | $20.8M | $144.7M | -$402M | $95.5M | $9.9M | |
| Cash From Investing | -$175.5M | $58.4M | -$489.8M | $20.9M | -$82.6M | |
| Dividends Paid (Ex Special Dividend) | -$2.1B | -$2.2B | -$2.6B | -$3.2B | -$3.6B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $741M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$756.2M | -$16.4M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $49.7B | $71.1B | -$22.7B | -$45.1B | $8.7B | |
| Cash From Financing | $47.2B | $69.9B | -$25.4B | -$48.3B | $5.1B | |
| Beginning Cash (CF) | $38.6B | $88.4B | $160.8B | $138B | $93.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $49.8B | $72.4B | -$22.8B | -$44.9B | $8.7B | |
| Ending Cash (CF) | $88.4B | $160.8B | $138B | $93.1B | $101.8B | |
| Levered Free Cash Flow | $2.5B | $2.3B | $3B | $3.4B | $3.6B | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $510.6M | $662.5M | $777.6M | $883.2M | -- | |
| Depreciation & Amoritzation | $96.5M | $90.1M | $89.3M | $84.2M | -- | |
| Stock-Based Compensation | $19.4M | $19.4M | $19.5M | $18.8M | -- | |
| Change in Accounts Receivable | $13.7M | $26M | $125.5M | $27.9M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $499.8M | $617.6M | $650.4M | $776.9M | -- | |
| Capital Expenditures | $39.7M | $17.9M | $20.5M | $18.2M | -- | |
| Cash Acquisitions | -$7.8M | -$411.1M | -- | -$100K | -- | |
| Cash From Investing | -$34M | -$417.6M | $78M | -$5M | -- | |
| Dividends Paid (Ex Special Dividend) | -$322.5M | -$363.3M | -$399.8M | -$418.5M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -$1.7M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$100K | -$16.4M | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $17.9B | -$29.3B | -$14.8B | -$8.8B | -- | |
| Cash From Financing | $17.6B | -$29.7B | -$15.3B | -$9.2B | -- | |
| Beginning Cash (CF) | $124.4B | $169.8B | $129.7B | $95.9B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $18B | -$29.5B | -$14.5B | -$8.5B | -- | |
| Ending Cash (CF) | $142.4B | $140.3B | $115.1B | $87.5B | -- | |
| Levered Free Cash Flow | $460.1M | $599.7M | $629.9M | $758.7M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.9B | $2.8B | $2.9B | $3.2B | $3.6B | |
| Depreciation & Amoritzation | $450M | $379.1M | $359.4M | $349.2M | $334M | |
| Stock-Based Compensation | $94.5M | $73.6M | $84.5M | $86M | $87.4M | |
| Change in Accounts Receivable | $191.5M | -$73.5M | -$118.3M | $96.3M | -$142.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.6B | $2.6B | $3.2B | $3.4B | $3.9B | |
| Capital Expenditures | $183.2M | $122.1M | $81.5M | $81M | $88.4M | |
| Cash Acquisitions | $14.6M | $150.9M | -$404.4M | $94.4M | $11M | |
| Cash From Investing | -$166.5M | $69.5M | -$484.1M | $15.3M | -$75.8M | |
| Dividends Paid (Ex Special Dividend) | -$2.1B | -$2.5B | -$3.1B | -$3.5B | -$3.8B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $742.7M | -- | -- | -- | |
| Long-Term Debt Repaid | $204.6M | -$756.1M | -- | -$16.4M | -$750M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $86.3B | $44.3B | -$39.7B | -$33.7B | $26.2B | |
| Cash From Financing | $84.1B | $42.7B | -$42.8B | -$37.2B | $22.4B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $86.5B | $45.4B | -$40.1B | -$33.7B | $26.2B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2.4B | $2.5B | $3.1B | $3.4B | $3.8B | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.1B | $1.4B | $1.7B | $1.7B | $956.2M | |
| Depreciation & Amoritzation | $194.7M | $182M | $178M | $169.5M | $82.5M | |
| Stock-Based Compensation | $41M | $39.4M | $39.7M | $42.1M | $21.2M | |
| Change in Accounts Receivable | -$132.5M | -$148M | -$115.7M | -$65.5M | -$196.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.1B | $1.4B | $1.6B | $1.7B | $1.1B | |
| Capital Expenditures | $68.2M | $41.3M | $35.7M | $38M | $14.2M | |
| Cash Acquisitions | -$14M | -$411.1M | -$2.4M | -$3.6M | -$2.4M | |
| Cash From Investing | -$68M | -$440.5M | $60.8M | -$27.8M | -$16M | |
| Dividends Paid (Ex Special Dividend) | -$1.5B | -$1.9B | -$2.4B | -$2.7B | -$2.6B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $741M | -- | -- | $742.3M | |
| Long-Term Debt Repaid | -- | -$756.2M | -$16.4M | -- | -$750M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $54.5B | -$19.5B | -$22B | -$4.5B | $21.8B | |
| Cash From Financing | $53B | -$21.5B | -$24.5B | -$7.3B | $19.2B | |
| Beginning Cash (CF) | $212.8B | $330.6B | $267.6B | $189B | $101.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $54B | -$20.5B | -$22.8B | -$5.6B | $20.3B | |
| Ending Cash (CF) | $266.8B | $310.1B | $244.8B | $183.4B | $122.1B | |
| Levered Free Cash Flow | $1B | $1.4B | $1.5B | $1.6B | $1.1B | |
Get CME Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CME
Sector
P/E ratio
27.92x
12.18x
PEG ratio
2.13x
0.40x
P/B ratio
3.70x
1.10x
Price / LTM sales
15.90x
2.66x
Growth Metrics
CME
Sector
Revenue growth
10.38%
5.1%
Earnings growth
11.49%
2.61%
Revenue (5-year growth)
4.72%
5.17%
Earnings forecast
$2.91
$0.61
Profitability
CME
Sector
Profitability FY 2024
$5.3B
$138.7M
Return on invested capital
11.8%
5.2%
Return on assets
2.63%
0.97%
Return on equity
13.28%
9.24%
Earnings Date
Last Earnings Date
Apr
23
Next Earnings Date
Jul
23
Estimated Next Earnings Date
Jul
23
Balance Sheet
CME
Sector
Total cash
$1.5B
$452M
Short term investments
$113.2M
$220.9M
Total assets
$137.4B
$3.8B
Long term debt
$3.4B
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is up 0.54% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.77% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 8.52% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
